NYSEARCA:KURE KraneShares MSCI All China Health Care Index ETF (KURE) Price, Holdings, & News $20.56 -0.12 (-0.60%) As of 03:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock About KraneShares MSCI All China Health Care Index ETF (NYSEARCA:KURE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get KURE alerts:Sign Up Key Stats Today's Range$20.48▼$21.3050-Day Range$16.52▼$20.6852-Week Range$13.11▼$21.30Volume379,581 shsAverage Volume80,577 shsMarket Capitalization$117.17 millionAssets Under Management$99.18 millionDividend Yield0.88%Net Expense Ratio0.65%Aggregate RatingBuy ETF Overview The KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is managed by KraneShares. Read More KraneShares MSCI All China Health Care Index ETF ExpensesTypeKUREHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.78%0.56%0.56%0.51%0.53%Other Expenses0.01%0.47%0.56%0.59%0.56%Total Expense0.79%0.75%0.76%0.74%0.73%Fee Waiver-0.14%-0.67%-0.66%-0.71%-0.63%Net Expense0.65%0.60%0.63%0.58%0.60% Receive KURE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KraneShares MSCI All China Health Care Index ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address KURE ETF News HeadlinesKURE: Capitalizing On China's Healthcare RevolutionJune 24, 2025 | seekingalpha.comNew Drivers For China Health Care: AI Med-Tech Innovation, Cancer Treatment, And Favorable Balance Of TradeMarch 18, 2025 | seekingalpha.comA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boom. For retirees, that could mean a way to generate reliable monthly income—without the outdated 4% withdrawal rule, risky trading, or high-fee annuities. If you’re ready to stop worrying about money running out and start enjoying the freedom to cover expenses, treat loved ones, and live life on your terms, this may be exactly what you’ve been waiting for.August 26 at 2:00 AM | Investors Alley (Ad)KraneShares Bosera MSCI China A 50 Connect Index ETF (KBA) Dividend HistoryMarch 2, 2025 | nasdaq.comChina Market Update: The Tale Of Two China’s & Their Investors Returns!November 11, 2024 | forbes.comAmundi MSCI World Health Care UCITS ETF EUR Acc (LYXHLTW)October 8, 2024 | investing.comSee More Headlines KURE ETF - Frequently Asked Questions How have KURE shares performed this year? KraneShares MSCI All China Health Care Index ETF's stock was trading at $14.19 at the start of the year. Since then, KURE shares have increased by 44.9% and is now trading at $20.56. How do I buy shares of KraneShares MSCI All China Health Care Index ETF? Shares of KURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of KraneShares MSCI All China Health Care Index ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that KraneShares MSCI All China Health Care Index ETF investors own include Alibaba Group (BABA), NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Visa (V), Micron Technology (MU) and Tesla (TSLA). Fund Details IssuerKraneShares Fund NameKraneShares MSCI All China Health Care Index ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:KURE Inception Date1/31/2018 Fund ManagerMark Schlarbaum WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMSCI China All Shares Health Care 10/40 Index CategorySector FocusHealth Care Development LevelEmerging Markets RegionAsia-Pacific Number of Holdings54 Fund Statistics Assets Under Management$97.63 million Average Daily Volume$119.56 thousand Discount/Premium0.31% Administrator, Advisor and Custodian AdministratorSEI Investments Global Funds Services AdvisorKrane Funds Advisors, LLC CustodianBrown Brothers Harriman & Co. DistributorSEI Investments Distribution Co. Transfer AgentBrown Brothers Harriman & Co. TrusteeN/A Lead Market MakerGTS Options OptionableOptionable Options Volume7 Put Options1 Call Options7 Short Interest41,600 shs Miscellaneous Outstanding Shares5,700,000Beta0.49 Creation Unit50,000 Creation Fee$1,320.00 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Top 10 KURE HoldingsBEONE MEDICINES LTD-HHolding Weight: 8.65%Jiangsu Hengrui Medicine Co., Ltd.Holding Weight: 8.08%WuXi Biologics (Cayman) Inc.Holding Weight: 6.75%Shenzhen Mindray Bio-Medical Electronics Co., Ltd.Holding Weight: 5.85%CSPC Pharmaceutical Group LimitedHolding Weight: 5.00%Akeso, Inc.Holding Weight: 4.85%Sino Biopharmaceutical LimitedHolding Weight: 4.59%Innovent Biologics, Inc.Holding Weight: 4.36%WuXi AppTec Co., Ltd.Holding Weight: 3.23%Hansoh Pharmaceutical Group Company LimitedHolding Weight: 2.98%Full Holdings DetailsKURE Sector ExposureKURE Industry Exposure This page (NYSEARCA:KURE) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KraneShares MSCI All China Health Care Index ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share KraneShares MSCI All China Health Care Index ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access